Raymond James Downgrades Ginkgo Bioworks Holdings to Market Perform, Announces $2.5 Price Target
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Rahul Sarugaser has downgraded Ginkgo Bioworks Holdings (NYSE:DNA) from Outperform to Market Perform and set a price target of $2.5.
November 14, 2023 | 3:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Ginkgo Bioworks Holdings was downgraded by Raymond James from Outperform to Market Perform with a new price target of $2.5.
Downgrades by analysts can lead to a negative perception among investors and potentially cause a short-term decline in the stock's price. The new price target of $2.5 may also set a lower expectation for the stock's future performance.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100